Colliers Securities Starts Lantern Pharma Inc. (LTRN) at Buy

July 28, 2020 7:42 AM EDT
Get Alerts LTRN Hot Sheet
Price: $5.71 --0%

Rating Summary:
    2 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 4 | Down: 12 | New: 10
Join SI Premium – FREE

Colliers Securities initiates coverage on Lantern Pharma Inc. (NASDAQ: LTRN) with a Buy rating and a price target of $24.00.

For an analyst ratings summary and ratings history on Lantern Pharma Inc. click here. For more ratings news on Lantern Pharma Inc. click here.

Shares of Lantern Pharma Inc. closed at $12.65 yesterday.

You May Also Be Interested In

Related Categories

New Coverage